Cargando…
Cognitive improvements and reduction in amyloid plaque deposition by saikosaponin D treatment in a murine model of Alzheimer's disease
Alzheimer's disease (AD), is a severe neurodegenerative disease that currently lacks an optimally effective therapeutic agent for its management. Saikosaponin D (SSD) is a component extracted from the herb Bupleurum falcatum that is commonly used in Chinese medicine. Although SSD has been repor...
Autores principales: | Zhou, Li, Huang, Jin-Yuan, Zhang, Di, Zhao, Ya-Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388258/ https://www.ncbi.nlm.nih.gov/pubmed/32742347 http://dx.doi.org/10.3892/etm.2020.8760 |
Ejemplares similares
-
2244 The effects of gravidity and parity on risk of cognitive impairment and amyloid plaque deposition
por: DiBiase, Rebecca, et al.
Publicado: (2018) -
Saikosaponin D improves chemosensitivity of glioblastoma by reducing the its stemness maintenance
por: Liang, Jin, et al.
Publicado: (2022) -
Formulations, Hemolytic and Pharmacokinetic Studies on Saikosaponin a and Saikosaponin d Compound Liposomes
por: Zhang, Guo-Song, et al.
Publicado: (2015) -
β-Sitosterol treatment attenuates cognitive deficits and prevents amyloid plaque deposition in amyloid protein precursor/presenilin 1 mice
por: Ye, Jian-Ya, et al.
Publicado: (2020) -
Neuroplastin 65 deficiency reduces amyloid plaque formation and cognitive deficits in an Alzheimer’s disease mouse model
por: Wu, Dan-Dan, et al.
Publicado: (2023)